Browse by all authors Browse By Author Name - Day,+RO

Browse Results (13 results found)

Subscribe to the RSS feed for this result setSubscribe to the RSS feed for this result set

  Abstract Views File Downloads Thomson Reuters Web of Science Citation Count Scopus Citation Count Altmetric Score
McLachlan, AJ, Tett, SE, Cutler, DJ and Day, RO (1993) Absorption and In-Vivo Dissolution of Hydroxycholoroquine in Fed Subjects Assessed Using Deconvolution Techniques. British Journal of Clinical Pharmacology, 36 5: 405-411. 79   8
Tett, SE, Cutler, DJ, Day, RO and Brown, KF (1988) A Dose-Ranging Study of the Pharmacokinetics of Hydroxychloroquine Following Intravenous Administration to Healthy-Volunteers. British Journal of Clinical Pharmacology, 26 3: 303-313. 36   61
Day, RO, Quinn, DI, Conaghan, PG and Tett, SE (1995) Adverse Drug-Reactions and Their Measurement in the Rheumatic Diseases. Journal of Rheumatology, 22 5: 983-988. 41   6
Tett, SE, Cutler, DJ and Day, RO (1992) Bioavailability of Hydroxychloroquine Tablets Assessed with Deconvolution Techniques. Journal of Pharmaceutical Sciences, 81 2: 155-159. doi:10.1002/jps.2600810211 28   25 0
Tett, SE, Cutler, DJ, Day, RO and Brown, KF (1989) Bioavailability of Hydroxychloroquine Tablets in Healthy-Volunteers. British Journal of Clinical Pharmacology, 27 6: 771-779. 32   61
McLachlan, AJ, Tett, SE, Cutler, DJ and Day, RO (1994) Bioavailability of Hydroxychloroquine Tablets in Patients with Rheumatoid-Arthritis. British Journal of Rheumatology, 33 3: 235-239. 27   13
Tett, SE, Day, RO and Cutler, DJ (1993) Concentration-Effect Relationship of Hydroxychloroquine in Rheumatoid-Arthritis - a Cross-Sectional Study. Journal of Rheumatology, 20 11: 1874-1879. 24   28
McLachlan, AJ, Tett, SE, Cutler, DJ and Day, RO (1994). Disposition and Absorption of Hydroxychloroquine Enantiomers Following a Single-Dose of the Racemate. In: Chirality. 4th International Symposium on Chiral Discrimination, Montreal Canada, (360-364). Sep 19-22, 1993. doi:10.1002/chir.530060421 24   11 Cited 7 times in Scopus7 0
McLachlan, AJ, Tett, SE, Cutler, DJ and Day, RO (1993) Disposition of the Enantiomers of Hydroxychloroquine in Patients with Rheumatoid-Arthritis Following Multiple Doses of the Racemate. British Journal of Clinical Pharmacology, 36 1: 78-81. 26   22
Brooks, PM and Day, RO (2001) Drug safety module: Summary and recommendations. Journal of Rheumatology, 28 5: 1192-1193. 36   0
Tett, SE, Cutler, DJ and Day, RO (1990). Hydroxychloroquine Concentrations and Clinical Effects in Rheumatoid-Arthritis Patients. In: European Journal of Pharmacology. , , (1035-1035). . doi:10.1016/0014-2999(90)92892-M 15   3 0
Welch, V, Singh, G, Strand, V, Fries, J, Boers, M, Ramey, D, Day, RO, Brooks, P, Tugwell, P, Clinch, J and Kristjansson, B (2001) Patient based method of assessing adverse events in clinical trials in rheumatology: the revised Stanford Toxicity Index. Journal of Rheumatology, 28 5: 1188-1191. 43   4
Tett, SE, McLachlan, AJ, Cutler, DJ and Day, RO (1994). Pharmacokinetics and Pharmacodynamics of Hydroxychloroquine Enantiomers in Patients with Rheumatoid-Arthritis Receiving Multiple Doses of Racemate. In: Chirality. 4th International Symposium on Chiral Discrimination, Montreal Canada, (355-359). Sep 19-22, 1993. doi:10.1002/chir.530060420 51   11 Cited 11 times in Scopus11 0